NEW YORK, May 18 (Reuters) - The head of research for Allergan Inc. said on Friday the company's anti-wrinkle Botox drug could transform the care of urinary incontinence and overactive bladder and ...

IRVINE, Calif., Nov. 7, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday ...

Building on the brand's 20-year legacy and real-world experience, the original BOTOX® Cosmetic continues to be the most researched and requested product of its kind.1,2 BOTOX® Cosmetic is trusted by ...

IRVINE, Calif., Sept. 9, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of "The One & Only" campaign, a ...

Botox, used for smoothing out wrinkles, is the number one selling neurotoxin globally Allergan Aesthetics’ main product Botox received Food and Drug Administration approval for a new indication in ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...

THE ICONIC BRAND ENCOURAGES PEOPLE TO TAKE A 'MOMENT FOR YOU' WITH TWO EXCLUSIVE OFFERS FOR FAMILY AND FRIENDS, POWERED BY ALLĒ Only new or existing Allē Members can participate in the exclusive BOGO ...

Mylan and Revance Therapeutics announced plans to develop and commercialize a biosimilar to Allergan’s Botox, TheStreet reports. Here’s what you should know. 1. Market analysts believe the deal puts ...

(Reuters) - Botox-maker Allergan Plc, which is in talks to be bought by Pfizer Inc, reported a better-than-expected quarterly profit on strong sales of high-margin branded drugs, its biggest business.

April 26 (Reuters) - The U.S. Food and Drug Administration said on Friday that fraudulent versions of the wrinkle treatment Botox, which is made by Allergan Inc and also used to treat headaches, ...

Allergan answers to Uncle Sam. Botox maker Allergan agreed Wednesday to pay $600 million to settle charges it illegally promoted and sold the beauty-enhancing drug through 2005 for unapproved uses ...